Day: November 30, 2022

Azerion publishes Interim Unaudited Q3 2022 Results

Continued growth and delivery on M&A pipeline Highlights of Q3 2022 Revenue of almost EUR 106 million, compared to EUR 84 million in Q3 2021, mainly driven by strong growth in the Platform segment. Adjusted EBITDA of over EUR 12 million, down by 30% compared to Q3 2021, primarily due

Conagen develops high-purity non-GMO sulforaphane by bioconversion

Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s

Azerion sets out its future strategic priorities

Amsterdam, 30 November 2022 – Today, Azerion has set out its strategic priorities in the journey to become the go-to-partner for advertisers for an easy-to-use, competitively priced and brand-safe digital environment. The Strategy Deep Dive presentation is available on www.azerion.com/investors. Umut Akpinar, co-CEO of Azerion, comments: “I am excited to share